Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
McKesson
Deloitte
Fish and Richardson
Cantor Fitzgerald
Express Scripts
Colorcon
Teva

Generated: November 18, 2018

DrugPatentWatch Database Preview

Desvenlafaxine succinate - Generic Drug Details

« Back to Dashboard

What are the generic sources for desvenlafaxine succinate and what is the scope of desvenlafaxine succinate freedom to operate?

Desvenlafaxine succinate is the generic ingredient in two branded drugs marketed by Actavis Labs Fl, Alembic Pharms Ltd, Casi Pharms Inc, Lupin Ltd, Mylan Pharms Inc, West-ward Pharms Int, Yichang Humanwell, Zydus Pharms Usa Inc, and Wyeth Pharms Inc, and is included in ten NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for desvenlafaxine succinate. Nineteen suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for desvenlafaxine succinate

US Patents and Regulatory Information for desvenlafaxine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204020-001 Oct 11, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-003 Aug 20, 2014 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Yichang Humanwell DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 210014-002 Oct 1, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Pharms Inc PRISTIQ desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 021992-001 Feb 29, 2008 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl DESVENLAFAXINE SUCCINATE desvenlafaxine succinate TABLET, EXTENDED RELEASE;ORAL 204065-002 Jul 29, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
McKesson
Deloitte
Fish and Richardson
Cantor Fitzgerald
Express Scripts
Colorcon
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.